Francesco Draetta
Director/Board Member bei Beta Bionics, Inc.
Ursprung des Netzwerks ersten Grades von Francesco Draetta
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Omega Fund Management LLC
 Omega Fund Management LLC Investment ManagersFinance Omega Fund Management Ltd. (OFM) is the wholly-owned private equity firm founded by Dr. Otello Stampacchia in 2004. The firm is headquartered in the US.
24
| Private Company | Investment Managers | 24 |
Beta Bionics, Inc.
 Beta Bionics, Inc. Medical SpecialtiesHealth Technology Beta Bionics, Inc. operates a medical technology company leveraging lifelong, machine-learning, artificial intelligence to develop and commercialize the autonomous bionic pancreas. The company was founded by Edward R. Damiano in October 21, 2015 and is headquartered in Boston, MA.
15
| Holding Company | Medical Specialties | 15 |
NRG Therapeutics Ltd.
 NRG Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services NRG Therapeutics Ltd. is a British neuroscience drug discovery company that focuses on building a pipeline of disease-modifying mitochondrial therapeutics to slow or halt the progression of neurodegenerative disorders such as Parkinson's and ALS. The company is based in Stevenage, UK, and was founded in 2018 by Neil Miller and Richard Rutter. The company's pre-clinical pipeline of small molecule assets is based on inhibiting the mitochondrial permeability transition pore (mptp) through a novel mechanism of action. Inhibition of the mptp has been shown to protect neurons, reduce neuroinflammation, and extend survival in pre-clinical disease models. Neil Miller has been the CEO since 2018.
7
| Holding Company | Miscellaneous Commercial Services | 7 |
| Private Company | Financial Conglomerates | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Francesco Draetta
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| THE NEW YORK TIMES COMPANY | Publishing: Newspapers | Director/Board Member | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Graduate Degree | |
Nuvation Bio Operating Co., Inc.
 Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Nuvation Bio Operating Co., Inc. engages in the provision of biotechnology company developing proprietary therapies focuse on oncology. It portfolio includes Seven Novel and Mechanistically Distinct Oncology Programs, Each with Multiple Drug Development Candidates. The company was founded by David Hung in 2018 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Director/Board Member Undergraduate Degree Corporate Officer/Principal Undergraduate Degree | |
Aerium Therapeutics, Inc.
 Aerium Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aerium Therapeutics, Inc. is an American biotechnology company that focuses on epidemic and pandemic preparedness. The company is based in Lausanne and has operations in the United States. The company's mission is to discover and develop antibodies and small molecule antivirals against SARS-CoV-2 and other epidemic and pandemic threats. Aerium Therapeutics has a team of world-class scientists and biotechnology veterans, as well as experienced investors. Aerium's lead assets are monoclonal antibodies that show broad activity against important variants of concern (VOCs) of SARS-CoV-2, including Omicron and its subvariants. The company plans to expand its pipeline to antiviral therapeutics in late 2022 and will broaden its focus to other epidemic and pandemic threats in the future. The CEO of the company is Rajeev Venkayya. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Chairman | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Corporate Officer/Principal Director of Finance/CFO Private Equity Investor | |
| NeoMed S.à.r.l. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
| GOSSAMER BIO, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Corporate Officer/Principal Director of Finance/CFO | |
Andrew Alliance SA
 Andrew Alliance SA Industrial MachineryProducer Manufacturing Andrew Alliance SA develops liquid handling solutions. Its product, Andrew, is a novel liquid handling robot designed for pipetting process. The firm's products include Andrew models, consumable dominos, protocol design, and enabling accessories. The company was founded by Piero Zucchelli, Giorgio Horak, and Antoine Jordan in March 2011 and is headquartered in Vernier, Switzerland. | Industrial Machinery | Director/Board Member Director/Board Member | |
| University of Geneva | College/University | Doctorate Degree Doctorate Degree | |
Artios Pharma Ltd.
 Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| MORPHIC HOLDING, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Chord Therapeutics SA
 Chord Therapeutics SA BiotechnologyHealth Technology Chord Therapeutics SA is a clinical stage pharmaceutical company. It develops drugs for patients with rare, life-threatening and severely disabling diseases. The firm offers CRD1. The company was founded by Arthur Roach and is headquartered in Geneva, Switzerland. | Biotechnology | Chairman Founder | |
Biosense Webster, Inc.
 Biosense Webster, Inc. Medical SpecialtiesHealth Technology Biosense Webster, Inc. develops technology solutions for diagnosing heart rhythm disorders. It provides deflectable tip catheter for treating arrhythmia disorder. The company was founded by Wilton W. Webster Jr. and Shlomo Ben-Haim in 1998 and is headquartered in South Diamond Bar, CA. | Medical Specialties | Sales & Marketing Corporate Officer/Principal | |
| REPLIMUNE GROUP, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| BLUEBIRD BIO, INC. | Biotechnology | Director/Board Member Chairman | |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Biotechnology | Director/Board Member Director/Board Member | |
| University of Oxford | College/University | Undergraduate Degree Undergraduate Degree | |
Cure Ventures Management LP
 Cure Ventures Management LP Investment ManagersFinance Cure Ventures Management LP (Cure Ventures) is a venture capital firm founded in 2021 by David R Fallace, Richard J Lim and Lou A Tartaglia. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Founder Private Equity Investor | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Graduate Degree | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree | |
| TRANSLATE BIO, INC. | Biotechnology | Chairman Director/Board Member | |
| University of Pavia | College/University | Graduate Degree Doctorate Degree | |
| ESSA PHARMA INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| KRONOS BIO, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| TREVI THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
EUSA Pharma, Inc.
 EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight products on the market, including Caphosol for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high-dose chemotherapy, ProstaScint for imaging the extent and spread of prostate cancer, Quadramet for the treatment of pain in patients whose cancer has spread to the bones, Erwinase and Kidrolase for the treatment of acute lymphoblastic leukemia and the antibiotic surgical implant Collatamp. EUSA also has several products in late-stage development, notably Collatamp topical, a gentamicin impregnated collagen sponge for the prevention and treatment of infected skin ulcers, and CollaRx bupivacaine implant for local post-surgical pain control. Founded in 2006, EUSA Pharma is supported by a consortium of leading life science capital investors, comprising TVM Capital, Essex Woodlands, 3i, Goldman Sachs, Advent Venture Partners, SV Life Sciences, NeoMed and NovaQuest. Since its foundation, the company has raised over $275 million, and completed several significant transactions, including the acquisitions of Cytogen Corporation, Talisker Pharma Ltd, the French biopharmaceutical company OPi SA and the European antibiotic and pain control business of Innocoll Pharmaceuticals Inc. As part of its rapid growth strategy the company has established commercial infrastructure in the US, a pan-European presence covering over 20 countries and a wider distribution network in a further 25 territories. EUSA Pharma plans to continue its aggressive program of acquisitions and in-licensing within its specialist areas of medical and geographic focus, in line with its ambitious target to create a rapidly growing $1 billion company by the beginning of the next decade. | Pharmaceuticals: Major | Director/Board Member | |
Syndesi Therapeutics SA
 Syndesi Therapeutics SA Miscellaneous Commercial ServicesCommercial Services Syndesi Therapeutics SA develops novel therapeutics for cognitive impairment which includes Alzheimer’s disease, dementias, and cognitive impairment associated with schizophrenia. The company is headquartered in Louvain-la-Neuve, Belgium. | Miscellaneous Commercial Services | Chief Executive Officer | |
| BICYCLE THERAPEUTICS PLC | Biotechnology | Corporate Officer/Principal | |
| The University of Manchester | College/University | Doctorate Degree | |
UCL Business Ltd.
 UCL Business Ltd. Miscellaneous Commercial ServicesCommercial Services UCL Business Plc operates as a technology transfer company. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Tricolor Holdings LLC
 Tricolor Holdings LLC Finance/Rental/LeasingFinance Tricolor Holdings LLC provides financial technology solutions. The company is based in Irving, TX and has subsidiaries in the United States. Tricolor Holdings was founded in 2007 by Daniel Chu, who has been the CEO since 2007. | Finance/Rental/Leasing | Director/Board Member | |
Lehigh Valley Health Network, Inc.
 Lehigh Valley Health Network, Inc. Medical/Nursing ServicesHealth Services Lehigh Valley Health Network, Inc. engages in the provision of healthcare services. It offers emergency care, express care, primary care, specialty care, video visits, pediatric video visits, testing and imaging, and rehabilitation services. The company is headquartered in Allentown, PA. | Medical/Nursing Services | Director/Board Member | |
Tricolor Auto Group LLC
 Tricolor Auto Group LLC Specialty StoresRetail Trade Tricolor Auto Group LLC provides car dealer ship and finance services. The firm specializes in auto financing, job opportunity, marketing, auto financing, hispanic market, sales, branding and auto industry. The company was founded by Daniel Chu in 2007 and is headquartered in Dallas, TX. | Specialty Stores | Director/Board Member | |
The Conference Board, Inc.
 The Conference Board, Inc. Miscellaneous Commercial ServicesCommercial Services The Conference Board, Inc. is a membership organization working for the public interests. It creates and disseminates knowledge about management and the marketplace to help businesses in their performance and to better serve the society. The firm publishes information and analysis, makes economics-based forecasts and assesses trends, and facilitates learning by creating communities of interest that bring together senior executives from around the world. The company was founded in 1916 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member | |
| IKENA ONCOLOGY, INC. | Biotechnology | Director/Board Member | |
| University of Cambridge | College/University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 28 |
| Schweiz | 6 |
| Vereinigtes Königreich | 6 |
| Belgien | 3 |
| Deutschland | 2 |
Sektoral
| Health Technology | 20 |
| Consumer Services | 11 |
| Finance | 8 |
| Commercial Services | 6 |
| Producer Manufacturing | 2 |
Operativ
| Director/Board Member | 259 |
| Corporate Officer/Principal | 66 |
| Independent Dir/Board Member | 55 |
| Private Equity Investor | 47 |
| Chairman | 44 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Michael Powell | 48 |
| Otello Stampacchia | 37 |
| John Maraganore | 37 |
| Daniel Lynch | 32 |
| Claudio Nessi | 25 |
| Beth Brooke | 24 |
| Dina Chaya | 23 |
| Sean Carney | 22 |
| Vincent Ossipow | 22 |
| Jonathan Leslie Tobin | 19 |
| Bernard Davitian | 19 |
| Joseph Slattery | 18 |
| Richard Lim | 17 |
| Jan van de Winkel | 15 |
| Roshawn Blunt | 14 |
- Börse
- Insiders
- Francesco Draetta
- Unternehmensverbindungen
